CN102813799A - Medicament for treating intractable skin disease - Google Patents
Medicament for treating intractable skin disease Download PDFInfo
- Publication number
- CN102813799A CN102813799A CN2012102942041A CN201210294204A CN102813799A CN 102813799 A CN102813799 A CN 102813799A CN 2012102942041 A CN2012102942041 A CN 2012102942041A CN 201210294204 A CN201210294204 A CN 201210294204A CN 102813799 A CN102813799 A CN 102813799A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- medicine
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating intractable skin diseases, and relates to the technical field of traditional Chinese medicine. The medicament is prepared from the following raw materials: 2-4 g of Schizonepeta, 2-4 g of radix sileris, 2-4 g of radix sophorae flavescentis, 2-4 g of rhizoma atractylodis, 2-4 g of salix leaf, 2-4 g of dandelion, 2-4 g of rhizoma anemarrhenae, 2-4 g of periostracum cicada, 2-4 g of burdock, 2-4 g of fructus cannabis, 2-4 g of radices rehmanniae, 2-4 g of gypsum, 2-4 g of Chinese angelica, 1-4 g of akebiaquinata and 1-4 g of licorice. The raw materials can be produced into commonly used pharmaceutical dosage forms, such as a powder, a pill, a capsule, a decoction and a lotion. The invention has the following beneficial effects: 1. the medicament has fast treatment effect, short treatment course and good treatment effect, and is proved to have a total effective rate of 98.6% by 72 clinical trial cases; 2. the manufacturing method is simple and convenient for production; and 3.the low-cost medicament is easily accepted by patients.
Description
Technical field
The present invention relates to technical field of Chinese medicines, further is a kind of Chinese medicine medicine that is used to treat refractory skin.
Background technology
Refractory skin is meant that clinical skin lesion is serious, does not touchingly heal outbreak repeatedly, one type of dermatosis of extremely difficult medical treatment.Comprise intractable psoriasis, eczema, anaphylactoid purpura, lupus erythematosus, vitiligo, ichthyosis, scleroderma, allergic dermatitis, urticaria, acne, chloasma etc.
The Along with people's growth in the living standard, the quickening of rhythm of life, stress increases, environmental pollution in addition, improper diet and motion shortcoming etc., increasing day by day appears in refractory skin.It had both influenced attractive in appearance, influenced the healthy of people again.
Therefore, research and develop out the novel drugs of treatment refractory skin, have active operation significance with good therapeutic effect.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of treating refractory skin, it is that raw material is processed with the Chinese herbal medicine, and therapeutic effect is good, taking convenience, and cost is lower.
The objective of the invention is to realize through following scheme:
A kind of medicine of treating refractory skin; It is characterized in that it being to process: Herba Schizonepetae 2-4 gram, windproof 2-4 gram, Radix Sophorae Flavescentis 2-4 gram, Rhizoma Atractylodis 2-4 gram, Folium Salicis Babylonicae 2-4 gram, Herba Taraxaci 2-4 gram, Rhizoma Anemarrhenae 2-4 gram, Periostracum Cicadae 2-4 gram, Fructus Arctii 2-4 gram, Fructus Cannabis 2-4 gram, Radix Rehmanniae 2-4 gram, Gypsum Fibrosum 2-4 gram, Radix Angelicae Sinensis 2-4 gram, Caulis Akebiae 1-4 gram, Radix Glycyrrhizae 1-4 gram by following raw material; During making, can be made into pharmaceutical dosage form commonly used, like powder; Pill; Capsule, decoction, one of lotion.
The present invention also can further realize through following scheme:
When said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.
When said making decoction or lotion, intense fire boils back slow fire to be fried in shallow oil slowly, to water surplus 1/3 o'clock, removes fiery filtering residue.
Among the present invention:
It is monarch drug that Herba Schizonepetae, windproof, Folium Salicis Babylonicae, larval moult, Herba Taraxaci, Radix Angelicae Sinensis have wind-dispelling heat-dissipating; The Radix Rehmanniae, evil reality, Fructus Cannabis Liang Run invigorate blood circulation; Be ministerial drug, Radix Sophorae Flavescentis, Rhizoma Atractylodis, the Rhizoma Anemarrhenae, Gypsum Fibrosum, Caulis Akebiae dampness reach thoroughly and are that adjuvant drug, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription and detoxifying and relieving itching are messenger drug.All medicines are harmonious, and form wind and heat dispersing altogether, the effect of detoxifying and relieving itching.
The beneficial effect of medicine according to the invention is: 1, curative effect is fast, short treating period, and therapeutic effect is good.Show that through 72 routine clinical trials total effective rate is 98.6%.2, manufacture method is simple, is convenient to produce.3, cost is low, and the patient is easy to accept.
Below, further set forth the beneficial effect of medicine according to the invention through the clinical observation on the therapeutic effect test.
Testing data:
1 Indications: rheumatic fever poison depression in the skin caused by Zhu Zheng intractable pruritus, urticaria, eczema, hives, skin itching, rash into a film into pieces, rash colored red, yellow water flow scratching, itching, abnormal , when the time is now hidden, long refractory persons.
2, case statistics: treat 72 examples, among the patient, male's 42 examples, women's 30 examples, age distribution is: 7 examples below 20 years old, 21~30 years old 15 example, 31~40 years old 17 example, 41~50 years old 19 example, 14 examples more than 50 years old, maximum age 67 years old, minimal ages 13 years old.
3, Therapeutic Method: once-a-day, restrain or 250 milliliters for a time 3.
4, efficacy assessment standard:
Cure: gargalesthesia is eliminated, and other symptom is eliminated basically;
Produce effects: gargalesthesia and other symptom obviously alleviate;
Effectively: gargalesthesia and other symptom alleviate to some extent;
Invalid: gargalesthesia and other symptom do not have change.
5, therapeutic effect:
7 days is a course of treatment, normally takes 3 courses of treatment continuously.Cure 37 examples, account for 51.4%; Produce effects 22 examples account for 30.5%, and effective 12 examples account for 16.7%, and invalid 1 example accounts for 1.4%, total effective rate 98.6%.
6, model case introduction:
Case 1: Ma, the woman, 53 years old, sour jujube Malin people from village pressed down in Hua County, Henan Province through the ages, suffered from the intractable skin itching several years; In many ways seek medical advice and do not feel any better, go to a doctor in March, 2008, observes whole skin and play pimple, very itches unbearably; Take 1 dose and take effect, 6 doses of recoveries from illness are followed up a case by regular visits to stablely, do not have recurrence.
Case 2: the Wang, the man, 47 years old, Hua County, Henan Province Lao Dianzhen people suffered from the intractable skin itching nearly one month, and go to a doctor in April, 2012, observes to show that skin is wet, mashed state, takes 1 dose and take effect, and 6 doses of recoveries from illness are followed up a case by regular visits to stablely, do not have recurrence.
Case 3: Liu, the man, 43 years old, people from Guzhen stayed in Hua County in Henan Province, suffered from intractable skin itching half a year, sought medical advice in many ways and do not feel any better, and go to a doctor in July, 2010, observes whole skin and be red and swollen pimple more, takes 1 dose and take effect, and 6 doses of recoveries from illness are followed up a case by regular visits to stablely, do not have recurrence.
The specific embodiment
In order to make those skilled in the art person understand the present invention program better, and make above-mentioned purpose of the present invention, feature and advantage can be more obviously understandable, below in conjunction with embodiment the present invention done further detailed explanation.
Embodiment 1:
A kind of medicine of treating refractory skin; Processed by following raw material: Herba Schizonepetae 2 grams, windproof 2 grams, Radix Sophorae Flavescentis 2 grams, Rhizoma Atractylodis 2 grams, Folium Salicis Babylonicae 2 grams, Herba Taraxaci 2 grams, the Rhizoma Anemarrhenae 2 grams, Periostracum Cicadae 2 grams, Fructus Arctii 2 grams, Fructus Cannabis 2 grams, Radix Rehmanniae 2 grams, Gypsum Fibrosum 2 grams, Radix Angelicae Sinensis 2 grams, Caulis Akebiae 1 gram, Radix Glycyrrhizae 1 gram during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, decoction or lotion.
Embodiment 2:
A kind of medicine of treating refractory skin; Processed by following raw material: Herba Schizonepetae 4 grams, windproof 4 grams, Radix Sophorae Flavescentis 4 grams, Rhizoma Atractylodis 4 grams, Folium Salicis Babylonicae 4 grams, Herba Taraxaci 4 grams, the Rhizoma Anemarrhenae 4 grams, Periostracum Cicadae 4 grams, Fructus Arctii 4 grams, Fructus Cannabis 4 grams, Radix Rehmanniae 4 grams, Gypsum Fibrosum 4 grams, Radix Angelicae Sinensis 4 grams, Caulis Akebiae 3 grams, Radix Glycyrrhizae 3 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, decoction or lotion.
Embodiment 3:
A kind of medicine of treating refractory skin; Processed by following raw material: Herba Schizonepetae 3 grams, windproof 3 grams, Radix Sophorae Flavescentis 3 grams, Rhizoma Atractylodis 3 grams, Folium Salicis Babylonicae 3 grams, Herba Taraxaci 3 grams, the Rhizoma Anemarrhenae 3 grams, Periostracum Cicadae 3 grams, Fructus Arctii 3 grams, Fructus Cannabis 34 grams, Radix Rehmanniae 3 grams, Gypsum Fibrosum 3 grams, Radix Angelicae Sinensis 3 grams, Caulis Akebiae 3 grams, Radix Glycyrrhizae 3 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, decoction or lotion.
Embodiment 4:
A kind of medicine of treating refractory skin; Processed by following raw material: Herba Schizonepetae 3 grams, windproof 3 grams, Radix Sophorae Flavescentis 3 grams, Rhizoma Atractylodis 3 grams, Folium Salicis Babylonicae 3 grams, Herba Taraxaci 3 grams, the Rhizoma Anemarrhenae 3 grams, Periostracum Cicadae 3 grams, Fructus Arctii 3 grams, Fructus Cannabis 3 grams, Radix Rehmanniae 3 grams, Gypsum Fibrosum 3 grams, Radix Angelicae Sinensis 3 grams, Caulis Akebiae 2 grams, Radix Glycyrrhizae 2 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, decoction or lotion.
When said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.Described pill can be a kind of of the watered pill, honeyed pill.
When said making decoction or lotion, intense fire boils back slow fire to be fried in shallow oil slowly, to water surplus 1/3 o'clock, removes fiery filtering residue.
The above; Be merely the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, any technical staff who is familiar with the present technique field is in the technical scope that the present invention discloses; The variation that can expect easily or replacement all should be encompassed within protection scope of the present invention.
Claims (5)
1. medicine of treating refractory skin; It is characterized in that it being to process: Herba Schizonepetae 2-4 gram, windproof 2-4 gram, Radix Sophorae Flavescentis 2-4 gram, Rhizoma Atractylodis 2-4 gram, Folium Salicis Babylonicae 2-4 gram, Herba Taraxaci 2-4 gram, Rhizoma Anemarrhenae 2-4 gram, Periostracum Cicadae 2-4 gram, Fructus Arctii 2-4 gram, Fructus Cannabis 2-4 gram, Radix Rehmanniae 2-4 gram, Gypsum Fibrosum 2-4 gram, Radix Angelicae Sinensis 2-4 gram, Caulis Akebiae 1-4 gram, Radix Glycyrrhizae 1-4 gram by following raw material; During making, can be made into pharmaceutical dosage form commonly used, like powder; Pill; Capsule, decoction, one of lotion.
2. the medicine of treatment refractory skin according to claim 1 is characterized in that it being that raw material is formed and to be: Herba Schizonepetae 3 grams, windproof 3 grams, Radix Sophorae Flavescentis 3 grams, Rhizoma Atractylodis 3 grams, Folium Salicis Babylonicae 3 grams, Herba Taraxaci 3 grams, the Rhizoma Anemarrhenae 3 grams, Periostracum Cicadae 3 grams, Fructus Arctii 3 grams, Fructus Cannabis 3 grams, Radix Rehmanniae 3 grams, Gypsum Fibrosum 3 grams, Radix Angelicae Sinensis 3 grams, Caulis Akebiae 3 grams, Radix Glycyrrhizae 3 grams.
3. the medicine of treatment refractory skin according to claim 1 is characterized in that it being that raw material is formed and to be: Herba Schizonepetae 3 grams, windproof 3 grams, Radix Sophorae Flavescentis 3 grams, Rhizoma Atractylodis 3 grams, Folium Salicis Babylonicae 3 grams, Herba Taraxaci 3 grams, the Rhizoma Anemarrhenae 3 grams, Periostracum Cicadae 3 grams, Fructus Arctii 3 grams, Fructus Cannabis 3 grams, Radix Rehmanniae 3 grams, Gypsum Fibrosum 3 grams, Radix Angelicae Sinensis 3 grams, Caulis Akebiae 2 grams, Radix Glycyrrhizae 2 grams.
4. the medicine of treatment refractory skin according to claim 1 is characterized in that: when said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.
5. the medicine of treatment refractory skin according to claim 1 is characterized in that: when said making decoction or lotion, intense fire boils back slow fire to be fried in shallow oil slowly, to water surplus 1/3 o'clock, removes fiery filtering residue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102942041A CN102813799A (en) | 2012-08-18 | 2012-08-18 | Medicament for treating intractable skin disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102942041A CN102813799A (en) | 2012-08-18 | 2012-08-18 | Medicament for treating intractable skin disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102813799A true CN102813799A (en) | 2012-12-12 |
Family
ID=47298481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012102942041A Pending CN102813799A (en) | 2012-08-18 | 2012-08-18 | Medicament for treating intractable skin disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102813799A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263528A (en) * | 2013-05-28 | 2013-08-28 | 庞金萍 | Externally used traditional Chinese medicine (euphorbia ebracteolata hayata) compound preparation for treating intractable skin diseases |
CN103933383A (en) * | 2014-03-20 | 2014-07-23 | 毛杰 | Traditional Chinese medicine for treating systemic lupus erythermatosus |
CN105853705A (en) * | 2016-04-11 | 2016-08-17 | 广州暨南生物医药研究开发基地有限公司 | Folium artemisiae argyi containing traditional Chinese medicine composition for treating acnes and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1166352A (en) * | 1997-02-19 | 1997-12-03 | 宋芳吉 | Wind dispelling and itching stopping medicine and its production |
CN1172674A (en) * | 1997-08-29 | 1998-02-11 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
CN1562320A (en) * | 2004-04-20 | 2005-01-12 | 邵丹 | Preparation of Chinese traditional medicine for curing skin disease |
-
2012
- 2012-08-18 CN CN2012102942041A patent/CN102813799A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1166352A (en) * | 1997-02-19 | 1997-12-03 | 宋芳吉 | Wind dispelling and itching stopping medicine and its production |
CN1172674A (en) * | 1997-08-29 | 1998-02-11 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
CN1562320A (en) * | 2004-04-20 | 2005-01-12 | 邵丹 | Preparation of Chinese traditional medicine for curing skin disease |
Non-Patent Citations (1)
Title |
---|
邓丙戌: "鲜药在皮肤病中医外治中的应用", 《中国中西医结合皮肤性病学杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263528A (en) * | 2013-05-28 | 2013-08-28 | 庞金萍 | Externally used traditional Chinese medicine (euphorbia ebracteolata hayata) compound preparation for treating intractable skin diseases |
CN103933383A (en) * | 2014-03-20 | 2014-07-23 | 毛杰 | Traditional Chinese medicine for treating systemic lupus erythermatosus |
CN105853705A (en) * | 2016-04-11 | 2016-08-17 | 广州暨南生物医药研究开发基地有限公司 | Folium artemisiae argyi containing traditional Chinese medicine composition for treating acnes and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101716330B (en) | Traditional Chinese medicine composition for treating angina disease and preparation method thereof | |
CN101693099B (en) | Traditional Chinese medicine composite for treating tachyrhythmia and its preparation method | |
CN101693089B (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
CN104288426A (en) | Traditional Chinese medicine lotion for treating senile cutaneous pruritus and preparation method thereof | |
CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
CN101874887B (en) | Chinese medicinal composition for treating angina and preparation method thereof | |
CN102861274A (en) | External use traditional Chinese medicine for treating eczema | |
CN102813799A (en) | Medicament for treating intractable skin disease | |
CN102743539B (en) | Traditional Chinese medicine for treating coronary heart disease with warming yang and promoting blood circulation effects, and preparation method for same | |
CN101837099B (en) | Chinese medicinal composition for curing intermenstrual bleeding and preparation method thereof | |
CN1857515B (en) | Skin care Chinese medicine film preparation and its preparing process | |
CN102579818A (en) | Traditional Tibetan medicine composition, preparation method thereof and application | |
CN101843819B (en) | Chinese medicament for treating psoriasis | |
CN100444871C (en) | Atoxic traditional Chinese medicine composition for treating rheumatosis and rheumatoid disease | |
CN104474045A (en) | Traditional Chinese medicine patch for treating febrile convulsion of infants and preparation method of traditional Chinese medicine patch | |
CN101143172A (en) | Traditional Chinese medicine for treating obesity in children | |
CN109172686A (en) | The Chinese medicine composition and its preparation method and application for treating senile skin pruritus | |
CN101716321A (en) | Traditional Chinese medicine composition for treating heart vessel blockage stasis disease and preparation method thereof | |
CN103638259A (en) | Traditional Chinese medicine pill for treating liver stagnation type irregular menstrual period | |
CN102872210B (en) | Traditional Chinese medicine for treating urticaria | |
CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN105963558A (en) | Plant extract for treating fever of children and application thereof | |
CN105497783A (en) | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma | |
CN104606636A (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof | |
CN104288618B (en) | A kind of Chinese medicine composition for treating children's psoriasis vulgaris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121212 |